In financial markets, the ticker symbol NRXP is used by investors and traders to buy and sell shares of NRx Pharmaceuticals on the Nasdaq stock exchange. Operationally, the enterprise utilizes its capital resources to fund clinical trials, regulatory submissions for psychiatric drugs like NRX-100 and NRX-101, and the commercialization of preservative-free ketamine formulations targeting severe depression and suicidal ideation.